The Impact of Liver and Renal Dysfunction on the Pharmacokinetics and Pharmacodynamics of Sedative and Analgesic Drugs in Critically Ill Adult Patients

Crit Care Nurs Clin North Am. 2016 Jun;28(2):183-94. doi: 10.1016/j.cnc.2016.02.009. Epub 2016 Mar 5.

Abstract

The use of sedative and analgesic drug therapy is often necessary for the care of critically ill patients. Renal and hepatic dysfunction, which occurs frequently in this patient population, can significantly alter drugs' pharmacokinetic and pharmacodynamics properties. By anticipating how these medications may be affected by liver or kidney dysfunction, health care practitioners may be able to provide tailored dosing regimens that ensure optimal comfort while minimizing the risk of adverse events.

Keywords: Analgesics; Critical care; Dysfunction; Hepatic; Pharmacodynamics; Pharmacokinetics; Renal; Sedatives.

Publication types

  • Review

MeSH terms

  • Analgesics / metabolism
  • Analgesics / pharmacokinetics*
  • Critical Care / methods
  • Critical Illness*
  • Drug Monitoring / methods
  • Drug Monitoring / nursing
  • Humans
  • Hypnotics and Sedatives / metabolism
  • Hypnotics and Sedatives / pharmacokinetics*
  • Kidney Diseases / complications
  • Kidney Diseases / metabolism*
  • Kidney Diseases / physiopathology
  • Kidney Function Tests
  • Liver Diseases / complications
  • Liver Diseases / metabolism*
  • Liver Diseases / physiopathology
  • Liver Function Tests

Substances

  • Analgesics
  • Hypnotics and Sedatives